U.S. Software Stock News

NasdaqCM:CPRX
NasdaqCM:CPRXBiotechs

Is Catalyst Pharmaceuticals (CPRX) Pricing Reflect Future Growth After Recent Share Price Pullback

If you are wondering whether Catalyst Pharmaceuticals is priced attractively or already reflects high expectations, you are not alone. That is exactly what this article will unpack. The share price recently closed at US$22.58, with a 15.6% return over the past year. Shorter term returns over 7 days, 30 days and year to date are a 3.0% decline, 4.0% decline and 2.5% decline respectively. Recent news flow around Catalyst Pharmaceuticals has focused on its role in the pharmaceuticals and...